Psychiatry and Neurology, Neurology · Carmel, CA
NPI
1033422142
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
275 Crossroads Blvd, A
Carmel, CA, 93923
Phone (831) 718-9701
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
8,826 services
Medicare patients, 2024
707
Average age 77
Drug cost, 2024
$879K
2,491 prescriptions
Company payments, 2025
$247
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter A Michas-Martin was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,196 times for 15 patients. In total Peter A Michas-Martin billed 8,826 services in 27 codes, and Medicare paid $217K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,196 | 15 | $4.83 | $30K |
| 90901 Behavioral Health Services | Office | 1,419 | 151 | $33.98 | $48K |
| 99214 Office E&M - Established | Office | 540 | 367 | $94.65 | $51K |
| 99215 Office E&M - Established | Office | 177 | 142 | $142.17 | $25K |
| 99483 Office/Outpatient Services | Office | 107 | 107 | $212.33 | $23K |
| 99205 Office E&M - New | Office | 105 | 105 | $163.83 | $17K |
| 99204 Office E&M - New | Office | 53 | 53 | $120.42 | $6,382 |
| 64615 Musculoskeletal | Office | 39 | 15 | $104.94 | $4,093 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 32 | $8.33 | $267 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 22 | 17 | $22.49 | $495 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 13 | $91.42 | $1,646 |
| 99213 Office E&M - Established | Office | 18 | 13 | $66.11 | $1,190 |
| 99443 Telephone Services | Office | 18 | 15 | $88.74 | $1,597 |
| 95957 Neurologic | Facility | 16 | 16 | $83.65 | $1,338 |
| 95816 Neurologic | Facility | 16 | 16 | $46.72 | $748 |
By year: 2022 $156K for 5,991 services; 2023 $188K for 6,980 services; 2024 $217K for 8,826 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter A Michas-Martin prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 473 prescriptions and refills. In total Peter A Michas-Martin wrote 2,491 Medicare prescriptions that cost $879K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 473 | 1,142 | 147 | $29K |
| Memantine Hcl Generic | 229 | 439 | 64 | $7,688 |
| Donepezil Hcl Generic | 204 | 548 | 62 | $2,882 |
| Rasagiline Mesylate Generic | 135 | 253 | 38 | $31K |
| Gabapentin Generic | 131 | 245 | 42 | $2,602 |
| Nourianz Istradefylline | 117 | 175 | 22 | $329K |
| Duloxetine Hcl Generic | 56 | 122 | 15 | $1,286 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 55 | 155 | 22 | $3,362 |
| Primidone Generic | 52 | 106 | 16 | $1,418 |
| Propranolol Hcl Generic | 52 | 89 | 17 | $1,138 |
| Lamotrigine Generic | 50 | 125 | 12 | $915 |
| Amantadine Amantadine Hcl | 48 | 100 | 15 | $2,027 |
| Sumatriptan Succinate Generic | 46 | 50 | 12 | $3,926 |
| Levetiracetam Generic | 45 | 122 | 14 | $1,999 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 43 | 94 | 14 | $1,439 |
Brand drugs: - claims; generic drugs: 2,133 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter A Michas-Martin $247 ($247 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $138.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.